| Christopher Anders Garcia, | |
|
9200 W Wisconsin Ave, Dept Of Pathology, Milwaukee, WI 53226-3522 | |
| (414) 805-6968 | |
| (414) 805-6980 |
| Full Name | Christopher Anders Garcia |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104143544 | NPI | - | NPPES |
| 1104143544 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 66094 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Anders Garcia, 9200 W Wisconsin Ave, Dept Of Pathology, Milwaukee, WI 53226-3522 Ph: (414) 805-6968 | Christopher Anders Garcia, 9200 W Wisconsin Ave, Dept Of Pathology, Milwaukee, WI 53226-3522 Ph: (414) 805-6968 |
News Archive
A cancer researcher at the University of Alberta has made a discovery that could unlock new ways to treat a rare blood disease.
Scientists have used DNA sequencing for the first time to effectively track the spread of, and ultimately contain, an outbreak of methicillin-resistant Staphylococcus aureus (MRSA), according to new research published in The Lancet Infectious Diseases.
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.
Some organizations, such as Dick Armey's FreedomWorks, are preparing to celebrate if the Supreme Court finds the health law unconstitutional. Meanwhile, the National Federation of Independent Business, which is one of the law's challengers, is working on very official and strategic responses. Insurers are working on their images.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
› Verified 3 days ago
Dr. James Vaughan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 8701 W Watertown Plank Rd, Milwaukee, WI 53226 Phone: 414-456-8296 | |
Dr. Elena V Roukhadze, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5000 W National Ave, Milwaukee, WI 53295 Phone: 414-384-2000 Fax: 414-389-4187 | |
Dr. Timothy Greenwell, MD Pathology Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-3666 Fax: 262-560-1579 | |
Waseem Anani, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 638 N 18th St, Milwaukee, WI 53233 Phone: 412-937-6358 | |
Dr. Neil L Drake, MD Pathology Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Department Of Pathology, Milwaukee, WI 53226 Phone: 414-805-6966 Fax: 414-805-6980 | |
Dr. Zeenath Asma, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St, Milwaukee, WI 53215 Phone: 414-647-5633 | |
Anthony Kohlenberg, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1271 N 6th St, Milwaukee, WI 53212 Phone: 414-978-9138 |